R M Tuttle Selected Research

Radioactive Fallout (Fallout, Radioactive)

5/2011	Clinical presentation and clinical outcomes in Chernobyl-related paediatric thyroid cancers: what do we know now? What can we expect in the future?
4/2000	The Chernobyl accident and its consequences: update at the millennium.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

R M Tuttle Research Topics

Disease

25	Thyroid Neoplasms (Thyroid Cancer) 01/2018 - 04/2000
14	Papillary Thyroid Cancer 02/2016 - 03/2000
11	Neoplasms (Cancer) 04/2014 - 04/2000
8	Neoplasm Metastasis (Metastasis) 07/2011 - 11/2000
7	Follicular Adenocarcinoma 09/2002 - 03/2000
5	Thyroid Diseases (Thyroid Disease) 09/2002 - 03/2000
3	Disease Progression 05/2013 - 07/2001
2	Type 2 Diabetes Mellitus (MODY) 01/2018 - 05/2015
2	Thyroid Nodule (Nodule, Thyroid) 01/2018 - 04/2001
1	medullary Thyroid cancer 01/2018
1	Multiple Endocrine Neoplasia Type 2a (MEN 2) 01/2018
1	Hypoxia (Hypoxemia) 04/2006
1	Adenoma (Adenomas) 09/2002
1	Goiter 09/2002
1	follicular Thyroid cancer 04/2002
1	Graves Disease (Basedow Disease) 04/2000
1	Autoimmune Diseases (Autoimmune Disease) 04/2000
1	Thyroiditis 04/2000

Drug/Important Bio-Agent (IBA)

7	IodineIBA 05/2013 - 04/2001
6	RacivirIBA 09/2002 - 03/2000
5	Thyroglobulin FDA Link 05/2011 - 03/2001
3	Thyrotropin Alfa FDA LinkGeneric 07/2011 - 04/2002
3	Thyroid HormonesIBA 07/2011 - 02/2001
3	Messenger RNA (mRNA)IBA 04/2006 - 03/2001
3	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 12/2005 - 02/2001
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2002 - 04/2000
2	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 01/2018 - 05/2015
2	Liraglutide FDA Link 01/2018 - 05/2015
2	Radioactive Fallout (Fallout, Radioactive)IBA 05/2011 - 04/2000
2	RNA (Ribonucleic Acid)IBA 04/2001 - 03/2001
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 04/2000 - 03/2000
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2018
1	dulaglutideIBA 01/2018
1	Glucagon-Like Peptide-1 ReceptorIBA 01/2018
1	Exenatide (Byetta)FDA Link 01/2018
1	Tyrosine Kinase InhibitorsIBA 05/2016
1	prolinedithiocarbamate (PDTC)IBA 04/2014
1	MAP Kinase Kinase 1IBA 05/2013
1	CobaltIBA 04/2006
1	Formaldehyde (Formol)FDA Link 04/2006
1	Erythropoietin FDA Link 04/2006
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 09/2002
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 09/2002
1	3-nitrotyrosineIBA 09/2002
1	Tissue Inhibitor of Metalloproteinase-1IBA 05/2002
1	A-factor (Streptomyces)IBA 05/2002
1	Matrix Metalloproteinase 14 (MT1-MMP)IBA 05/2002
1	Matrix Metalloproteinases (MMPs)IBA 05/2002
1	Telomerase (Telomerase Reverse Transcriptase)IBA 04/2002
1	DNA Repair EnzymesIBA 04/2002
1	DNA (Deoxyribonucleic Acid)IBA 04/2002
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 12/2001
1	ParaffinIBA 05/2001
1	sodium-iodide symporter (sodium iodide symporter)IBA 04/2001
1	SymportersIBA 04/2001
1	SodiumIBA 04/2001
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 03/2001
1	transgelinIBA 03/2001
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 03/2001
1	Thyroxine (Levothyroxine)FDA LinkGeneric 03/2001
1	Leukocyte Common Antigens (CD45 Antigen)IBA 03/2001
1	Radioisotopes (Radionuclides)IBA 01/2001
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 11/2000
1	AutoantibodiesIBA 04/2000
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 04/2000
1	AntibodiesIBA 04/2000

Therapy/Procedure

8	Therapeutics 01/2018 - 12/2001
3	Thyroidectomy 08/2012 - 09/2001
1	Neck Dissection (Radical Neck Dissection) 02/2016
1	Injections 12/2005
1	Nuclear Power Plants 04/2000